Mirae Asset Global Investments Co. Ltd. Sells 1,925 Shares of The Chemours Company (NYSE:CC)

Mirae Asset Global Investments Co. Ltd. trimmed its stake in The Chemours Company (NYSE:CC) by 6.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 29,264 shares of the specialty chemicals company’s stock after selling 1,925 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Chemours were worth $923,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of CC. Bank of New York Mellon Corp grew its holdings in shares of Chemours by 11.0% during the third quarter. Bank of New York Mellon Corp now owns 6,196,063 shares of the specialty chemicals company’s stock worth $173,800,000 after purchasing an additional 612,071 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Chemours by 10.0% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,160,740 shares of the specialty chemicals company’s stock worth $88,659,000 after purchasing an additional 286,076 shares during the last quarter. Deutsche Bank AG grew its holdings in shares of Chemours by 4,407.9% during the third quarter. Deutsche Bank AG now owns 1,759,419 shares of the specialty chemicals company’s stock worth $49,352,000 after purchasing an additional 1,720,389 shares during the last quarter. American Century Companies Inc. grew its holdings in shares of Chemours by 0.7% during the third quarter. American Century Companies Inc. now owns 1,459,463 shares of the specialty chemicals company’s stock worth $40,938,000 after purchasing an additional 10,075 shares during the last quarter. Finally, Vaughan Nelson Investment Management L.P. grew its holdings in shares of Chemours by 2.9% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 1,352,326 shares of the specialty chemicals company’s stock worth $37,934,000 after purchasing an additional 37,590 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently commented on CC. BMO Capital Markets upgraded Chemours from an “underperform” rating to an “outperform” rating and increased their target price for the stock from $19.00 to $34.00 in a report on Tuesday, April 9th. UBS Group upped their price target on Chemours from $21.00 to $28.00 and gave the company a “neutral” rating in a research note on Tuesday, April 2nd. Finally, Barclays cut their price target on Chemours from $32.00 to $30.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 2nd. Seven research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $30.89.

Chemours Trading Up 1.1 %

NYSE:CC opened at $26.73 on Wednesday. The Chemours Company has a 1-year low of $15.10 and a 1-year high of $39.05. The business’s 50-day moving average price is $26.72 and its two-hundred day moving average price is $27.80. The company has a current ratio of 1.54, a quick ratio of 1.00 and a debt-to-equity ratio of 5.40. The firm has a market capitalization of $3.98 billion, a price-to-earnings ratio of -17.25 and a beta of 2.00.

Chemours (NYSE:CC) last released its earnings results on Wednesday, March 27th. The specialty chemicals company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.02. Chemours had a positive return on equity of 51.73% and a negative net margin of 3.80%. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. On average, equities analysts expect that The Chemours Company will post 2.23 earnings per share for the current year.

Chemours Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Monday, February 26th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 3.74%. The ex-dividend date was Friday, February 23rd. Chemours’s payout ratio is -64.52%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.